Selected article for: "acute respiratory failure and severe acute ARDS respiratory distress syndrome"
Author: Gozzi-Silva, Sarah Cristina; Benard, Gil; Alberca, Ricardo Wesley; Yendo, Tatiana Mina; Teixeira, Franciane Mouradian Emidio; Oliveira, Luana de Mendonça; Beserra, Danielle Rosa; Pietrobon, Anna Julia; de Oliveira, Emily Araujo; Branco, Anna Cláudia Calvielli Castelo; Andrade, Milena Mary de Souza; Fernandes, Iara Grigoletto; Pereira, Nátalli Zanete; Ramos, Yasmim Álefe Leuzzi; Lima, Julia Cataldo; Provenci, Bruna; Mangini, Sandrigo; Duarte, Alberto José da Silva; Sato, Maria Notomi
Title: SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report
  • Cord-id: gnlmav6f
  • Document date: 2021_2_10
    • ID: gnlmav6f
    Snippet: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomi
    Document: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomitant infections that may also influence the prognoses. Herein, we describe the first report of two cases of HT recipients with concomitant infections by SARS-CoV-2, Trypanosoma cruzi, and cytomegalovirus (CMV) dissemination, from the first day of hospitalization due to COVID-19 in the intensive care unit (ICU) until the death of the patients.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and liver transplant: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and liver transplant recipient: 1
    • acute ards respiratory distress syndrome and lymphocyte high neutrophil: 1, 2
    • acute ards respiratory distress syndrome and lymphocyte high neutrophil ratio: 1, 2
    • acute ards respiratory distress syndrome and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte neutrophil ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute rejection and adipose tissue: 1
    • acute rejection and liver transplant: 1, 2, 3, 4, 5, 6, 7
    • acute rejection and liver transplant recipient: 1, 2
    • adipose tissue and long term administration: 1
    • adipose tissue and lymphocyte neutrophil: 1
    • adipose tissue and lymphocyte neutrophil ratio: 1
    • liver transplant and lymphocyte neutrophil: 1
    • liver transplant and lymphocyte neutrophil ratio: 1